Dr Reddy’s jumps on medical cannabis train, buying Nimbus Health
pharmaphorum
FEBRUARY 3, 2022
India’s Dr Reddy’s Laboratories has joined the growing list of pharma companies that are looking to tap into the market for medical cannabis, buying German developer Nimbus Health for an undisclosed sum. While the regulatory framework for cannabinoid products remains fragmented and hard to navigate around the world, Germany has emerged as an early-mover.
Let's personalize your content